Call for Abstract
Scientific Program
Pharmaceutical Summit and Expo, will be organized around the theme “Novel Strategies and Innovations in Global Pharmaceutical Market”
Pharma Summit 2015 is comprised of 13 tracks and 81 sessions designed to offer comprehensive sessions that address current issues in Pharma Summit 2015.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Preformulation studies and accelerated stability studies
- Track 1-2Nanotechnology in drug delivery system
- Track 1-3Major challenges in drug delivery systems
- Track 1-4Recent advances in targeted drug delivery systems
- Track 1-5Vaccine drug delivery systems
- Track 1-6Lipid drug delivery system
- Track 2-1Analytical IQ, OQ and PQ
- Track 2-2Modern pharmaceutical analytical techniques
- Track 2-3Analytical method development and validation
- Track 2-4UPLC and HPLC techniques
- Track 2-5Electroanalytical methods
- Track 2-6Current trends in gravimetric analysis
- Track 2-7Qualitative & quantitative elemental analysis
- Track 2-8Surface characterization techniques for chemical & physical analysis
- Track 3-1Clinical Pharmacology
- Track 3-2Recent advances in neuro and psycho pharmacology
- Track 3-3Pharmacogenetics and pharmacogenomics
- Track 3-4Recent toxicological studies and its issues
- Track 3-5Pharmacoepidemiology and drug safety
- Track 3-6Current advances in the pharmacology and physiology of trp channels
- Track 5-1Biomarker research, development and technology
- Track 5-2Disease related and drug related biomarkers
- Track 5-3Latest partnership and collaboration strategies and case studies on biomarker discovery, verification and validation
- Track 5-4 Challenges and regulatory approach for biosimilars
- Track 5-5 Clinical studies and clinicians prospects for biosimilars
- Track 5-6Biosimilars innovator pharmaceutical products
- Track 5-7Measurable parameters for customized therapies
- Track 5-8Future of next generation biosimilars
- Track 6-1Drug discovery research in pharmacognosy
- Track 6-2Drugs from natural sources and its availabity
- Track 6-3Herbal drugs and its documentation procedures
- Track 6-4Toxicology studies of plant products
- Track 6-5Phytochemistry and phytoconstituents
- Track 6-6Industrial pharmacognosy
- Track 7-1Regulatory requirements for pharmaceuticals and health care products
- Track 7-2Intellectual property law for generics and innovator rights
- Track 7-3FDA regulations and compliance strategies
- Track 7-4Novel strategies for growth in regulatory affairs
- Track 7-5Regulatory requirements for medical devices
- Track 7-6Regulatory issues, quality control and business development
- Track 7-7Intellectual property rights
- Track 8-1Drug safety methods
- Track 8-2Detection of adverse effects and other drug related problems
- Track 8-3Pharmacoepidemology and drug safety
- Track 8-4Safety monitoring of medicinal products
- Track 8-5Ongoing and systematic monitoring of the safety of cosmetics
- Track 8-6Set up & implimentation of cosmetovigilance system
- Track 9-1Current good manufacturing practices guidelines
- Track 9-2Quality assurance, quality control and SOP
- Track 9-3Current regulations and quality standards
- Track 9-4Role of c in cGMP
- Track 9-5Good clinical practices & good laboratory practices according to ICH
- Track 9-6Management of product storage, transportation and distribution
- Track 10-1Scope of contemporary pharmacy practice
- Track 10-2New dimensions of pharmacy practice
- Track 10-3Ethics in pharmacy and its policies
- Track 10-4Clinical laboratory practice
- Track 10-5Global standards in pharmacy practice
- Track 10-6New drug applications and fundamental drug development
- Track 11-1Clinical pharmacy & its key role in treatment
- Track 11-2Role of clinical pharmacist
- Track 11-3Dispensing pharmacy and research chemists
- Track 11-4High performance genetic analysis, fluid dispensing modeling
- Track 11-5Clinical drug development and therapeutics
- Track 11-6Pharmacotherapy
- Track 11-7Pharma waste and its disposal
- Track 11-8Environmental health hazards
- Track 12-1Current developments in medicinal chemistry
- Track 12-2Diagnostic and bioinorganic medicinal chemistry
- Track 12-3Green techniques for organic synthesis and medicinal chemistry
- Track 12-4Advances in Drug discovery
- Track 12-5Plant and microbial derived drugs in Drug discovery
- Track 12-6Recent advances in fluorinated pharmaceuticals based on natural products
- Track 13-1Drug discovery and development
- Track 13-2Pharmaceutical Technology
- Track 13-3Industrial pharmaceutics
- Track 13-4Clinical studies
- Track 13-5Dosage form design, development and manufacturing
- Track 13-6Waste and product management
- Track 13-7Post- marketing surveillance
- Track 13-8Marketing